Aerie Pharmaceuticals
AERI
$15.25
Share price
0.00%
Change (1 day)
83.73%
Change (1 year)
Categories
Earnings for Aerie Pharmaceuticals (AERI)
Earnings in 2022 (TTM): -$23.25 M
According to Aerie Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$23.25 M. In 2021 the company made an earning of -$45.32 M an increase over its 2020 earnings that were of -$0.16 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Aerie Pharmaceuticals from 2013 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$23.25 M | -48.71% |
| 2021 | -$45.32 M | -70.07% |
| 2020 | -$0.16 B | -17.91% |
| 2019 | -$0.19 B | -19.83% |
| 2018 | -$0.24 B | 59.2% |
| 2017 | -$0.15 B | 50% |
| 2016 | -$96.33 M | 34.29% |
| 2015 | -$71.74 M | 51% |
| 2014 | -$47.51 M | 73.67% |
| 2013 | -$27.36 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Merck MRK | $3.03 B | -13,158.82% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | -$0.18 B | 662.10% | 🇺🇸 USA |
 Insmed INSM | -$0.68 B | 2,786.09% | 🇺🇸 USA |